These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3527617)

  • 1. Clinical aspects of islet B-cell function in non-insulin-dependent diabetes mellitus.
    Ward WK; Beard JC; Porte D
    Diabetes Metab Rev; 1986; 2(3-4):297-313. PubMed ID: 3527617
    [No Abstract]   [Full Text] [Related]  

  • 2. Islet defects and insulin resistance in models of obese non-insulin-dependent diabetes.
    Bailey CJ; Flatt PR
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():43S-50S. PubMed ID: 8299488
    [No Abstract]   [Full Text] [Related]  

  • 3. The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity.
    Duman BS; Turkoglu C; Gunay D; Cagatay P; Demiroglu C; Buyukdevrim AS
    Diabetes Nutr Metab; 2003 Aug; 16(4):243-50. PubMed ID: 14768774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of insulin secretion in obesity and diabetes.
    Polonsky KS
    Int J Obes Relat Metab Disord; 2000 Jun; 24 Suppl 2():S29-31. PubMed ID: 10997604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subnormal secretion of insulin in mild diabetes mellitus.
    Floyd JC; Fajans SS; Conn JW; Pek S; Knopf RF
    Adv Metab Disord; 1970; 1():Suppl 1:113+. PubMed ID: 4914346
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible?
    Cerasi E
    Diabetologia; 1995 Aug; 38(8):992-7. PubMed ID: 7589888
    [No Abstract]   [Full Text] [Related]  

  • 7. Type II diabetes, glucose "non-sense," and islet desensitization.
    Robertson RP
    Diabetes; 1989 Dec; 38(12):1501-5. PubMed ID: 2684709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.
    Evans AJ; Krentz AJ
    Diabetes Obes Metab; 2001 Aug; 3(4):219-29. PubMed ID: 11520301
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum immunoreactive insulin levels during glucose tolerance and intensive islet stimulation. Effect of prednisone.
    Ryan WG; Schwartz TB; Nibbe AF
    Diabetes; 1971 Jun; 20(6):410-5. PubMed ID: 4933891
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathophysiology of insulin secretion in diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Porte D
    Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Pfeifer MA; Porte D
    Diabetes Care; 1984; 7(5):491-502. PubMed ID: 6094129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors controlling release of insulin from beta cell in relation to diabetes mellitus.
    Romanoff NE
    N Y State J Med; 1968 Feb; 68(3):385-91. PubMed ID: 4865846
    [No Abstract]   [Full Text] [Related]  

  • 13. The pathogenesis of NIDDM: the role of the pancreatic beta cell.
    Zawalich WS; Kelley GG
    Diabetologia; 1995 Aug; 38(8):986-91. PubMed ID: 7589887
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glucotoxicity and insulin secretion. An excessively reductionistic formulation].
    Portha B; Ktorza A
    Journ Annu Diabetol Hotel Dieu; 1996; ():121-31. PubMed ID: 8965414
    [No Abstract]   [Full Text] [Related]  

  • 15. Islet dysfunction in non-insulin-dependent diabetes mellitus.
    Kahn SE; Porte D
    Am J Med; 1988 Nov; 85(5A):4-8. PubMed ID: 3057894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of insulin induced by amino acids and glucose in diabetes mellitus.
    Floyd JC; Fajans SS; Conn JW; Thiffault C; Knopf RF; Guntsche E
    J Clin Endocrinol Metab; 1968 Feb; 28(2):266-76. PubMed ID: 4865756
    [No Abstract]   [Full Text] [Related]  

  • 17. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.
    DeFronzo RA
    Diabetes; 1988 Jun; 37(6):667-87. PubMed ID: 3289989
    [No Abstract]   [Full Text] [Related]  

  • 18. Excessive serum insulin response to oral glucose in obesity and mild diabetes. Study of 501 patients.
    Chiles R; Tzagournis M
    Diabetes; 1970 Jun; 19(6):458-64. PubMed ID: 4912051
    [No Abstract]   [Full Text] [Related]  

  • 19. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance.
    Mauvais-Jarvis F; Sobngwi E; Porcher R; Riveline JP; Kevorkian JP; Vaisse C; Charpentier G; Guillausseau PJ; Vexiau P; Gautier JF
    Diabetes; 2004 Mar; 53(3):645-53. PubMed ID: 14988248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the effects of insulin secretagogues in humans.
    Wallace TM; Matthews DR
    Diabetes Obes Metab; 2000 Oct; 2(5):271-83. PubMed ID: 11225742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.